1. Home
  2. CHD vs ILMN Comparison

CHD vs ILMN Comparison

Compare CHD & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Church & Dwight Company Inc.

CHD

Church & Dwight Company Inc.

HOLD

Current Price

$95.80

Market Cap

22.4B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$129.48

Market Cap

19.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHD
ILMN
Founded
1846
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.4B
19.4B
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
CHD
ILMN
Price
$95.80
$129.48
Analyst Decision
Buy
Hold
Analyst Count
17
17
Target Price
$102.41
$124.24
AVG Volume (30 Days)
1.7M
1.3M
Earning Date
05-01-2026
04-30-2026
Dividend Yield
1.29%
N/A
EPS Growth
27.43
170.87
EPS
3.02
5.45
Revenue
$6,203,200,000.00
$4,343,000,000.00
Revenue This Year
$0.27
$6.52
Revenue Next Year
$3.65
$5.60
P/E Ratio
$31.43
$23.37
Revenue Growth
1.57
N/A
52 Week Low
$81.33
$69.88
52 Week High
$106.12
$155.53

Technical Indicators

Market Signals
Indicator
CHD
ILMN
Relative Strength Index (RSI) 50.55 56.31
Support Level $95.28 $127.99
Resistance Level $96.26 $136.86
Average True Range (ATR) 2.01 5.14
MACD 0.37 0.53
Stochastic Oscillator 80.63 79.60

Price Performance

Historical Comparison
CHD
ILMN

About CHD Church & Dwight Company Inc.

Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. Most recently, the firm added Touchland and its hand sanitizer business to its fold. Even as it works to expand its product reach, Church & Dwight still derives around 80% of its sales from its home market in the US.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: